Structures by: Losev E. A.
Total: 104
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
CrystEngComm (2013) 15, 9 1693
a=4.9180(6)Å b=20.285(8)Å c=10.1651(13)Å
α=85.65(2)° β=113.352(9)° γ=88.33(2)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
CrystEngComm (2013) 15, 9 1693
a=4.8468(6)Å b=20.177(4)Å c=10.0209(12)Å
α=85.32(2)° β=113.602(9)° γ=88.180(19)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.8787(3)Å b=8.2985(4)Å c=13.070(2)Å
α=81.714(8)° β=87.395(8)° γ=82.183(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.7365(3)Å b=8.0902(4)Å c=12.894(2)Å
α=82.422(8)° β=88.028(8)° γ=82.178(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=6.3489(4)Å b=8.8785(5)Å c=13.387(3)Å
α=81.965(10)° β=85.674(10)° γ=84.251(5)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.7996(3)Å b=8.1816(4)Å c=12.978(3)Å
α=82.064(9)° β=87.702(9)° γ=82.134(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.7694(3)Å b=8.1369(4)Å c=12.941(3)Å
α=82.207(9)° β=87.842(9)° γ=82.147(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=6.0717(3)Å b=8.5574(5)Å c=13.251(2)Å
α=81.402(9)° β=86.675(9)° γ=82.667(5)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.9953(3)Å b=8.4598(4)Å c=13.189(2)Å
α=81.453(9)° β=86.954(9)° γ=82.427(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=6.1901(4)Å b=8.6946(6)Å c=13.321(3)Å
α=81.572(11)° β=86.221(10)° γ=83.180(5)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.8398(3)Å b=8.2425(4)Å c=13.031(3)Å
α=81.891(8)° β=87.556(8)° γ=82.156(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.8913(3)Å b=8.5944(15)Å c=12.8846(15)Å
α=80.681(12)° β=85.494(7)° γ=85.723(9)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.7168(4)Å b=8.3457(14)Å c=12.6434(10)Å
α=81.4960(10)° β=84.436(7)° γ=85.470(11)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.9669(3)Å b=8.6945(18)Å c=12.9785(9)Å
α=80.432(10)° β=85.884(5)° γ=85.774(8)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.8202(3)Å b=8.536(5)Å c=12.7885(14)Å
α=80.81(2)° β=85.069(6)° γ=85.606(14)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=6.0542(6)Å b=8.807(3)Å c=13.095(2)Å
α=80.05(2)° β=86.260(11)° γ=85.728(19)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.9122(3)Å b=8.617(4)Å c=12.9150(17)Å
α=80.610(19)° β=85.576(7)° γ=85.688(12)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.7692(2)Å b=8.421(2)Å c=12.7212(11)Å
α=81.231(12)° β=84.740(5)° γ=85.557(9)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8492(8)Å b=9.3222(11)Å c=20.646(3)Å
α=90° β=103.324(13)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8563(7)Å b=9.3274(9)Å c=20.671(3)Å
α=90° β=103.494(11)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8349(7)Å b=9.3138(10)Å c=20.579(3)Å
α=90° β=103.032(12)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8433(7)Å b=9.3162(10)Å c=20.618(3)Å
α=90° β=103.172(12)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8107(6)Å b=9.3013(8)Å c=20.411(3)Å
α=90° β=102.337(10)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8221(6)Å b=9.3052(9)Å c=20.493(3)Å
α=90° β=102.666(10)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8165(6)Å b=9.3035(8)Å c=20.450(3)Å
α=90° β=102.500(10)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8273(7)Å b=9.3086(9)Å c=20.535(3)Å
α=90° β=102.850(11)° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.1071(11)Å b=11.3252(12)Å c=23.827(4)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.1330(11)Å b=11.3031(13)Å c=23.884(4)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.0808(11)Å b=11.3449(12)Å c=23.766(4)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.0565(10)Å b=11.3647(12)Å c=23.719(4)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.0324(10)Å b=11.3875(11)Å c=23.665(3)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=8.0056(9)Å b=11.4027(11)Å c=23.615(3)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=7.9837(10)Å b=11.4209(12)Å c=23.589(3)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=7.9445(11)Å b=11.4431(14)Å c=23.524(4)Å
α=90° β=90° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=7.9621(10)Å b=11.4304(13)Å c=23.548(4)Å
α=90° β=90° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8316(3)Å b=9.291(2)Å c=20.4354(15)Å
α=90° β=102.972(6)° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8193(3)Å b=9.2205(12)Å c=18.9807(13)Å
α=99.010(8)° β=93.373(6)° γ=96.474(8)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8011(3)Å b=9.1664(13)Å c=18.8557(16)Å
α=99.072(9)° β=93.873(6)° γ=96.313(8)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.7793(3)Å b=9.0995(12)Å c=18.7215(16)Å
α=99.175(8)° β=94.392(6)° γ=96.158(8)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.7548(3)Å b=9.0519(10)Å c=18.5909(11)Å
α=99.268(7)° β=94.920(5)° γ=95.865(7)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.7294(3)Å b=9.0150(12)Å c=18.4226(14)Å
α=99.561(8)° β=95.475(6)° γ=94.927(8)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.7136(3)Å b=8.9774(10)Å c=18.3305(11)Å
α=99.633(7)° β=95.811(5)° γ=94.695(6)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.6911(3)Å b=8.9235(11)Å c=18.2045(11)Å
α=99.652(7)° β=96.245(5)° γ=94.537(7)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.7036(3)Å b=8.9504(12)Å c=18.2696(14)Å
α=99.640(8)° β=96.012(6)° γ=94.585(8)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.6691(3)Å b=8.8675(10)Å c=18.0795(11)Å
α=99.614(7)° β=96.706(5)° γ=94.481(7)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=5.9272(3)Å b=8.3697(4)Å c=13.124(2)Å
α=81.580(8)° β=87.185(8)° γ=82.254(4)°
Tolazamide
C14H21N3O3S
CrystEngComm (2017) 19, 16 2243
a=6.2278(5)Å b=9.026(2)Å c=13.3215(14)Å
α=79.608(13)° β=86.913(8)° γ=85.990(13)°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8067(6)Å b=9.3033(8)Å c=20.367(2)Å
α=90° β=102.159(10)° γ=90°
Glycine-phthalic acid (1:1)
C8H6O4,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=7.8988(8)Å b=11.3424(12)Å c=23.327(10)Å
α=90° β=90° γ=90°
Glycine-DL-tartaric acid (1:1)
C4H6O6,C2H5NO2
CrystEngComm (2016) 18, 31 5869
a=4.8540(4)Å b=9.3349(11)Å c=19.2555(15)Å
α=98.866(8)° β=92.311(6)° γ=96.887(8)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9195(5)Å b=8.5997(7)Å c=12.0667(10)Å
α=108.576(8)° β=97.152(8)° γ=92.576(8)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9272(5)Å b=8.6072(9)Å c=12.1525(13)Å
α=108.617(10)° β=97.370(9)° γ=92.763(9)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9101(5)Å b=8.5883(7)Å c=11.9978(9)Å
α=108.535(8)° β=96.969(8)° γ=92.427(8)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9001(5)Å b=8.5768(6)Å c=11.9523(9)Å
α=108.503(7)° β=96.781(7)° γ=92.316(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9010(4)Å b=8.5623(7)Å c=11.9502(11)Å
α=108.338(8)° β=96.669(8)° γ=92.426(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9089(5)Å b=8.5742(7)Å c=11.9896(10)Å
α=108.411(8)° β=96.813(8)° γ=92.501(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9142(5)Å b=8.5934(7)Å c=12.0281(10)Å
α=108.563(8)° β=97.059(8)° γ=92.493(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9248(5)Å b=8.6012(7)Å c=12.1074(10)Å
α=108.584(8)° β=97.257(8)° γ=92.666(8)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.9271(5)Å b=8.6022(8)Å c=12.1449(11)Å
α=108.606(8)° β=97.351(9)° γ=92.714(8)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8902(3)Å b=9.4430(4)Å c=21.7426(11)Å
α=90° β=103.096(5)° γ=90°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3453(3)Å b=9.1929(5)Å c=13.4917(7)Å
α=79.103(5)° β=87.266(4)° γ=85.857(5)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3506(6)Å b=9.2241(9)Å c=13.4984(13)Å
α=79.091(8)° β=87.215(8)° γ=85.815(8)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3346(3)Å b=9.1641(5)Å c=13.4642(7)Å
α=79.222(4)° β=87.305(4)° γ=85.936(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3186(5)Å b=9.1502(8)Å c=13.4244(11)Å
α=79.314(7)° β=87.303(7)° γ=85.948(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8745(3)Å b=9.4321(4)Å c=21.7086(11)Å
α=90° β=102.948(5)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8426(4)Å b=9.4084(5)Å c=21.6903(13)Å
α=90° β=103.248(7)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8333(3)Å b=9.4082(4)Å c=21.6923(15)Å
α=90° β=103.401(7)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8594(3)Å b=9.4225(4)Å c=21.7038(10)Å
α=90° β=103.092(5)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8784(5)Å b=9.4546(4)Å c=21.7693(6)Å
α=90° β=103.002(5)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8531(3)Å b=9.4182(4)Å c=21.7022(12)Å
α=90° β=103.155(6)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8828(3)Å b=9.4372(4)Å c=21.7258(11)Å
α=90° β=103.007(6)° γ=90°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8873(3)Å b=9.4416(4)Å c=21.7392(11)Å
α=90° β=103.063(6)° γ=90°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3064(5)Å b=9.1298(7)Å c=13.3984(11)Å
α=79.397(7)° β=87.344(7)° γ=85.986(6)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2891(3)Å b=9.0960(4)Å c=13.3659(5)Å
α=79.436(4)° β=87.381(3)° γ=86.026(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2586(2)Å b=9.0748(4)Å c=13.3249(5)Å
α=79.432(3)° β=87.442(3)° γ=85.975(3)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2738(3)Å b=9.0824(4)Å c=13.3414(5)Å
α=79.449(4)° β=87.415(3)° γ=86.013(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.4468(3)Å b=9.0141(5)Å c=13.4850(7)Å
α=82.360(4)° β=85.368(4)° γ=85.553(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3939(3)Å b=8.9809(4)Å c=13.5213(7)Å
α=82.129(4)° β=85.602(4)° γ=85.341(4)°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.3358(8)Å b=8.9455(11)Å c=13.5482(15)Å
α=81.976(10)° β=85.919(10)° γ=85.273(10)°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.2256(7)Å b=5.67647(16)Å c=32.0621(7)Å
α=90° β=100.170(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.2633(8)Å b=5.67322(19)Å c=32.0530(8)Å
α=90° β=100.076(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.3300(7)Å b=5.67423(16)Å c=32.0776(7)Å
α=90° β=99.937(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.3889(8)Å b=5.67352(19)Å c=32.0754(8)Å
α=90° β=99.818(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.4563(9)Å b=5.67251(19)Å c=32.0779(8)Å
α=90° β=99.653(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.5229(9)Å b=5.6692(2)Å c=32.0754(9)Å
α=90° β=99.486(4)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.6021(9)Å b=5.6701(2)Å c=32.0856(9)Å
α=90° β=99.299(4)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.6777(9)Å b=5.66500(18)Å c=32.0878(8)Å
α=90° β=99.115(3)° γ=90°
<i>L</i>-Leucinium hydrogen maleate
C6H14NO2,C4H3O4
Acta Crystallographica Section B (2019) 75, 2
a=21.7528(11)Å b=5.6663(2)Å c=32.0956(10)Å
α=90° β=98.955(4)° γ=90°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9022(7)Å b=20.901(3)Å c=10.2730(15)Å
α=90.00° β=114.600(10)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9110(7)Å b=20.922(3)Å c=10.2744(15)Å
α=90.00° β=114.586(10)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8960(6)Å b=20.878(2)Å c=10.2701(13)Å
α=90.00° β=114.634(9)° γ=90.00°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9098(7)Å b=20.194(3)Å c=10.1777(15)Å
α=85.571(13)° β=113.118(10)° γ=88.306(12)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9155(7)Å b=20.215(3)Å c=10.1862(16)Å
α=85.578(14)° β=113.133(11)° γ=88.301(13)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.9021(7)Å b=20.167(3)Å c=10.1686(15)Å
α=85.540(11)° β=113.122(10)° γ=88.270(11)°
Glutaric acid--glycine (1/1)
C5H8O4,C2H5NO2
Acta Crystallographica Section B (2012) 68, 3 287-296
a=4.8952(6)Å b=20.151(3)Å c=10.1585(13)Å
α=85.518(11)° β=113.088(9)° γ=88.264(11)°
Glycinium semi-malonate
C2H6NO2,C3H3O4
Acta Crystallographica Section C (2011) 67, 8 o297-o300
a=10.1431(19)Å b=8.1729(11)Å c=9.260(2)Å
α=90.00° β=101.879(16)° γ=90.00°
Glutaric acid--glycine (1/1)
C2H5NO2,C5H8O4
Acta Crystallographica Section C (2011) 67, 8 o297-o300
a=4.8954(4)Å b=20.8944(14)Å c=10.8462(8)Å
α=90.00° β=120.648(6)° γ=90.00°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7.5NO2,C4H5.5O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8948(5)Å b=8.5707(7)Å c=11.9179(9)Å
α=108.459(7)° β=96.649(8)° γ=92.235(7)°
Β-Alanine—–<i>DL</i>-tartaric acid (1/1)
C3H7NO2,C4H6O6
Acta Crystallographica Section C (2019) 75, 3
a=4.8491(8)Å b=9.4313(6)Å c=21.7481(10)Å
α=90° β=103.272(9)° γ=90°
Tolazamide
C14H21N3O3S
Acta Crystallographica Section C (2019) 75, 5 598-608
a=6.2433(2)Å b=9.0724(4)Å c=13.3119(5)Å
α=79.359(4)° β=87.461(3)° γ=85.933(3)°